Clinical Trials

Showing trials with last updates posted in 2025.

NCT06921824 | COMPLETED | NA
16 Participants

Investigating the Acute Effects of Increasing Glucagon Exposure in Healthy Participants

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-31
Completion: 2025-09-19
Conditions
Glucose Metabolism Glucagon
Interventions
OTHER
No Results Yet
NCT06920043 | RECRUITING | PHASE2
42 Participants

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-09
Completion: 2027-11-30
Conditions
Metabolic Dysfunction-Associated Steatohepatitis
Interventions
DRUG
No Results Yet
NCT06917313 | RECRUITING | PHASE2
92 Participants

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-12-05
Completion: 2028-03-31
Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions
DRUG
No Results Yet
NCT06916806 | RECRUITING | PHASE1
72 Participants

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-01
Completion: 2027-06-22
Conditions
Systemic Lupus Erythematosus Idiopathic Inflammatory Myopathies Rheumatoid Arthritis
Interventions
DRUG
No Results Yet
NCT06914895 | RECRUITING | PHASE3
905 Participants

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-25
Completion: 2027-05-31
Conditions
Type 1 Diabetes Obesity Overweight
Interventions
DRUG
No Results Yet
NCT06912633 | RECRUITING | PHASE2
60 Participants

Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-20
Completion: 2026-09-30
Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL OTHER
No Results Yet
NCT06909565 | RECRUITING | PHASE4
6000 Participants

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-23
Completion: 2029-10-31
Conditions
Percutaneous Coronary Intervention Peripheral Endovascular Intervention
Interventions
DRUG
No Results Yet
NCT06901544 | COMPLETED
100 Participants

Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-04
Completion: 2025-08-01
Conditions
Intra-Abdominal Infections Intestinal Obstruction Appendicitis Acute Perforated Viscus
NCT06897475 | RECRUITING | PHASE2
240 Participants

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-28
Completion: 2026-12-31
Conditions
Type 2 Diabetes
Interventions
DRUG
No Results Yet
NCT06881784 | RECRUITING | PHASE3
420 Participants

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-06
Completion: 2027-12-01
Conditions
NSCLC (Non-small Cell Lung Cancer) Non-Small Cell Lung Cancer NSCLC NSCLC (Non-small Cell Lung Carcinoma) NSCLC (Advanced Non-small Cell Lung Cancer)
Interventions
DRUG
No Results Yet
NCT06880055 | RECRUITING
3375 Participants

Shield Post-Approval Study Protocol

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-14
Completion: 2030-09-01
Conditions
Colo-rectal Cancer
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT06875115 | COMPLETED | NA
60 Participants

Evaluation of the Efficacy of Laser Acupuncture on Uremic Pruritus

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-04-09
Completion: 2024-05-11
Conditions
Uremia
Interventions
DEVICE
NCT06871410 | RECRUITING | PHASE1
26 Participants

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2026-01-15
Completion: 2028-04-01
Conditions
Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia
Interventions
DRUG PROCEDURE OTHER
No Results Yet
NCT06865651 | RECRUITING | PHASE2
44 Participants

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-22
Completion: 2027-09-01
Conditions
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Interventions
DRUG
No Results Yet
NCT06864104 | ACTIVE_NOT_RECRUITING | PHASE2
206 Participants

A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-10
Completion: 2026-01-09
Conditions
Hypertension
Interventions
DRUG
No Results Yet
NCT06864026 | RECRUITING | PHASE4
200 Participants

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-06
Completion: 2027-11-30
Conditions
Psoriatic Arthritis Overweight or Obesity
Interventions
DRUG
No Results Yet
NCT06853860 | COMPLETED | NA
70 Participants

Effects of Hand Massage Applied With Two Different Methods

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-15
Completion: 2025-05-15
Conditions
Angiopathy, Peripheral Pain, Acute Reflexology
Interventions
OTHER
No Results Yet
NCT06853158 | RECRUITING | NA
90 Participants

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-02
Completion: 2027-01-31
Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT06851559 | RECRUITING | PHASE2
80 Participants

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-10-30
Completion: 2026-12-31
Conditions
Eosinophilic Esophagitis
Interventions
DRUG
No Results Yet
NCT06849947 | NOT_YET_RECRUITING | PHASE2
272 Participants

Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2026-02-01
Completion: 2031-06-30
Conditions
Breast Cancer Metastatic
Interventions
DRUG
No Results Yet
NCT06844318 | RECRUITING
153 Participants

Impact of IBD Activity on Frailty in Patients Over 60 Years

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-14
Completion: 2026-04-30
Conditions
IBD
No Results Yet
NCT06843252 | RECRUITING | NA
16 Participants

Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-09-02
Completion: 2026-12-31
Conditions
Huntington Disease
Interventions
DEVICE
No Results Yet
NCT06841874 | NO_LONGER_AVAILABLE

Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC

Study Type: EXPANDED_ACCESS
Last Updated: 2025-12-24
Conditions
Bronchogenic Carcinoma Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Neoplasms Lung Diseases Respiratory Tract Diseases Carcinoma Non Small Cell Carcinoma of the Lung ROS1-positive Non-Small Cell Lung Cancer (NSCLC)
Interventions
DRUG
No Results Yet
NCT06839235 | RECRUITING | PHASE1/PHASE2
23 Participants

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-16
Completion: 2029-03-31
Conditions
Primary Hyperoxaluria Type 1 (PH1)
Interventions
DRUG
No Results Yet
NCT06834347 | RECRUITING | PHASE3
210 Participants

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-12
Completion: 2027-01-08
Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG
No Results Yet
NCT06831552 | RECRUITING | NA
84 Participants

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-30
Completion: 2029-06-01
Conditions
Neuroblastoma High-risk Neuroblastoma
Interventions
BEHAVIORAL
No Results Yet
NCT06830759 | RECRUITING
700 Participants

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-28
Completion: 2031-09-30
Conditions
Diffuse Large B-cell Lymphoma Follicular Lymphoma
No Results Yet
NCT06830720 | RECRUITING
3250 Participants

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-20
Completion: 2030-06-30
Conditions
Breast Neoplasms
Interventions
DRUG
No Results Yet
NCT06827457 | COMPLETED | PHASE1
58 Participants

A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-20
Completion: 2025-11-27
Conditions
Autoimmune Disease
Interventions
DRUG
No Results Yet
NCT06825702 | RECRUITING | PHASE2
28 Participants

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-01
Completion: 2026-11-30
Conditions
Macular Edema
Interventions
DRUG
No Results Yet
NCT06822426 | RECRUITING | PHASE3
200 Participants

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-14
Completion: 2027-01-31
Conditions
Central Line Associated Blood Stream Infections (CLABSI)
Interventions
DRUG
No Results Yet
NCT06820957 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
437 Participants

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-11-10
Completion: 2032-07-15
Conditions
CIC-Rearranged Sarcoma Metastatic Ewing Sarcoma Metastatic High Grade Sarcoma Metastatic Undifferentiated Round Cell Sarcoma Metastatic Undifferentiated Sarcoma, Not Otherwise Specified Round Cell Sarcoma With EWSR1-non-ETS Fusion Sarcoma With BCOR Genetic Alterations
Interventions
PROCEDURE DRUG OTHER RADIATION
No Results Yet
NCT06817512 | ACTIVE_NOT_RECRUITING | NA
190 Participants

Ischemic Stroke Nutrition Intervention Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-23
Completion: 2027-01-15
Conditions
Ischemic Stroke
Interventions
DIETARY_SUPPLEMENT
No Results Yet
NCT06817356 | RECRUITING | PHASE2
300 Participants

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-06
Completion: 2026-08-31
Conditions
Alcohol Use Disorder
Interventions
DRUG
No Results Yet
NCT06814743 | COMPLETED | NA
107 Participants

A Mobile Application for Female Athletes With Pelvic Floor Dysfunctions (ACTITUD2.0)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-10
Completion: 2025-06-30
Conditions
Pelvic Floor Disorders
Interventions
BEHAVIORAL
No Results Yet
NCT06810505 | RECRUITING | PHASE3
420 Participants

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-02-13
Completion: 2031-03-31
Conditions
Chronic Migraine
Interventions
DRUG
No Results Yet
NCT06807580 | RECRUITING | PHASE2
40 Participants

Progesterone in Gender Affirming Hormone Therapy Study

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-12
Completion: 2027-02-28
Conditions
Transgender Women
Interventions
DRUG
No Results Yet
NCT06803602 | ENROLLING_BY_INVITATION | NA
2100 Participants

HIFEM Technology for Post-Radical Prostatectomy and Post-Holmium Laser Prostate Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-01
Completion: 2027-03-31
Conditions
Holmium Laser Prostate Surgery Radical Prostatectomy
Interventions
DEVICE
No Results Yet
NCT06798012 | RECRUITING | PHASE2
36 Participants

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-14
Completion: 2027-12-02
Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Interventions
BIOLOGICAL
No Results Yet
NCT06791512 | RECRUITING | PHASE3
166 Participants

mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-01-18
Completion: 2030-12-31
Conditions
Colorectal Cancer (CRC) pMMR/MSS Adenocarcinoma of the Colon or Rectum
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page